by
Thomas Dworetzky, Contributing Reporter | April 05, 2017
The combined efforts will also expand and enhance R&D capabilities.
As an example of such research advances, Canon noted that it has proprietary high-speed dynamic X-ray imaging sensor technology, among other imaging devices, along with associated elemental technologies; photoacoustic tomography technology selected by Japan’s national ImPACT program; medical robotic system technologies, and minimally-invasive technologies.
Ad Statistics
Times Displayed: 109208
Times Visited: 6638 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The technologies, combined with Toshiba Medical’s R&D capabilities, will let Canon “globally provide innovative new products and services in the future,” it stated.
Canon has forecast full-year operating profit to rise 11.4 percent, helped by Toshiba Medical's earnings. That's the first rise in the last three years, according to
a report in The Star Online.
The acquisition of Toshiba Medical Systems is part of Phase V of Canon's Excellent Global Corporation Plan, a five-year initiative launched in 2016.
“Canon aims to embrace the challenge of new growth through a grand strategic transformation,” it said in a statement in February concerning its Toshiba acquisition. One of the most important parts of its strategy, it stressed, was “to cultivate its health care business.”
Back to HCB News
